PriceTargets.com logo

Agiliti - AGTI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $13.67
  • Forecasted Upside: 35.99%
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$10.05 As of 05/6/2024 07:40 PM ET
▼ -0.05 (-0.50%)
Get New Agiliti Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGTI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGTI

Analyst Price Target is $13.67
▲ +35.99% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Agiliti in the last 3 months. The average price target is $13.67, with a high forecast of $23.00 and a low forecast of $8.00. The average price target represents a 35.99% upside from the last price of $10.05.

This chart shows the closing price for AGTI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 polled investment analysts is to hold stock in Agiliti. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/26/2024Raymond JamesReiterated RatingMarket Perform ➝ Market Perform
3/7/2024UBS GroupReiterated RatingBuy ➝ Neutral$10.00
2/6/2024KeyCorpInitiated CoverageSector Weight
1/4/2024Craig HallumInitiated CoverageBuy$23.00
11/14/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$10.00 ➝ $8.00
11/14/2023UBS GroupUpgradeNeutral ➝ Buy$16.00 ➝ $10.00
9/5/2023Bank of AmericaDowngradeNeutral ➝ Underperform$18.00 ➝ $11.00
8/24/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$15.00 ➝ $10.00
8/15/2023CitigroupDowngradeBuy ➝ Neutral$20.00 ➝ $13.00
8/10/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$18.00 ➝ $15.00
8/10/2023Raymond JamesDowngradeOutperform ➝ Market Perform
8/9/2023KeyCorpLower TargetOverweight ➝ Overweight$23.00 ➝ $20.00
3/8/2023CitigroupLower TargetBuy$21.00 ➝ $20.00
1/6/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$18.00
12/16/2022Bank of AmericaDowngradeBuy ➝ Neutral$19.00
11/16/2022UBS GroupLower Target$19.00
11/15/2022Raymond JamesLower TargetOutperform$22.00 ➝ $20.00
11/14/2022The Goldman Sachs GroupLower TargetBuy$23.00 ➝ $20.00
11/13/2022CitigroupLower TargetBuy$24.00 ➝ $21.00
11/11/2022KeyCorpLower TargetOverweight$25.00 ➝ $23.00
10/11/2022Morgan StanleyLower TargetOverweight$23.00 ➝ $20.00
8/15/2022Raymond JamesLower TargetOutperform$25.00 ➝ $22.00
8/11/2022Morgan StanleyLower TargetOverweight$25.00 ➝ $23.00
8/10/2022KeyCorpLower TargetOverweight$27.00 ➝ $25.00
7/15/2022Morgan StanleyBoost TargetOverweight$22.00 ➝ $25.00
4/6/2022BMO Capital MarketsBoost TargetOutperform$22.00 ➝ $28.00
3/11/2022The Goldman Sachs GroupLower TargetBuy ➝ Buy$32.00 ➝ $28.00
3/11/2022Raymond JamesLower TargetOutperform$30.00 ➝ $25.00
3/10/2022Morgan StanleyLower TargetOverweight$30.00 ➝ $24.00
3/9/2022CitigroupLower TargetBuy$28.00 ➝ $25.00
1/18/2022The Goldman Sachs GroupLower TargetBuy$37.00 ➝ $32.00
11/12/2021Raymond JamesBoost TargetOutperform$25.00 ➝ $30.00
11/10/2021KeyCorpBoost TargetOverweight$23.00 ➝ $27.00
9/17/2021Raymond JamesBoost TargetOutperform$22.50 ➝ $25.00
8/16/2021Morgan StanleyBoost TargetOverweight$21.00 ➝ $23.00
8/16/2021KeyCorpBoost TargetOverweight$21.00 ➝ $23.00
5/24/2021BMO Capital MarketsInitiated CoverageOutperform$18.00
5/18/2021Raymond JamesInitiated CoverageOutperform$16.50
5/18/2021CitigroupInitiated CoverageBuy
5/18/2021UBS GroupInitiated CoverageNeutral$16.00
5/18/2021The Goldman Sachs GroupInitiated CoverageBuy$43.00
5/18/2021BMO Capital MarketsInitiated CoverageOutperform$18.00
5/18/2021Morgan StanleyInitiated CoverageOverweight$21.00
5/18/2021KeyCorpInitiated CoverageOverweight$21.00
5/18/2021Bank of AmericaInitiated CoverageBuy$18.00
5/18/2021Jefferies Financial GroupInitiated CoverageBuy$20.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Agiliti logo
Agiliti, Inc., together with its subsidiaries, provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services that are comprehensive programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity. It also provides clinical engineering services comprising maintenance, repair, and remediation solutions for various types of medical equipment, including general biomedical equipment, diagnostic imaging equipment, and surgical equipment through supplemental and outsourced offerings. In addition, the company offers equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. It serves acute care hospitals, health systems and integrated delivery networks and alternate site providers. The company was founded in 1939 and is headquartered in Eden Prairie, Minnesota. Agiliti, Inc. operates as a subsidiary of THL Agiliti LLC.
Read More

Today's Range

Now: $10.05
Low: $10.05
High: $10.10

50 Day Range

MA: $10.06
Low: $10.01
High: $10.15

52 Week Range

Now: $10.05
Low: $5.07
High: $18.61

Volume

26,512,199 shs

Average Volume

1,781,391 shs

Market Capitalization

$1.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Agiliti?

The following Wall Street analysts have issued stock ratings on Agiliti in the last year: Craig Hallum, KeyCorp, Morgan Stanley, Raymond James, TheStreet, and UBS Group AG.
View the latest analyst ratings for AGTI.

What is the current price target for Agiliti?

3 Wall Street analysts have set twelve-month price targets for Agiliti in the last year. Their average twelve-month price target is $13.67, suggesting a possible upside of 36.0%. Craig Hallum has the highest price target set, predicting AGTI will reach $23.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $8.00 for Agiliti in the next year.
View the latest price targets for AGTI.

What is the current consensus analyst rating for Agiliti?

Agiliti currently has 1 sell rating, 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AGTI, but not buy more shares or sell existing shares.
View the latest ratings for AGTI.

What other companies compete with Agiliti?

Other companies that are similar to Agiliti include Certara, Accolade, Forian, SCWorx and Aclarion. Learn More about companies similar to Agiliti.

How do I contact Agiliti's investor relations team?

The company's listed phone number is (952) 893-3200 and its investor relations email address is [email protected]. The official website for Agiliti is www.agilitihealth.com. Learn More about contacing Agiliti investor relations.